Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ronak Zareardalan"'
Autor:
Yousef Najajreh, Ronak Zareardalan, Saman Maleki Vareki, Meng Zhang, James Koropatnick, Xiufen Zheng, Mikal El-Hajjar, Rene Figueredo, Peter J. Ferguson, Faizah Alotaibi, Wei-Ping Min, Mateusz Rytelewski
Publikováno v:
European Journal of Immunology. 50:695-704
CD5 is expressed on T cells and a subset of B cells (B1a). It can attenuate TCR signalling and impair CTL activation and is a therapeutic targetable tumour antigen expressed on leukemic T and B cells. However, the potential therapeutic effect of func
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6dd3eb35393748ac87daa025e4898ef
https://doi.org/10.1002/eji.201948309
https://doi.org/10.1002/eji.201948309
Autor:
Saman Maleki Vareki, Xiufen Zheng, Meng Zhang, Ronak Zareardalan, Yousef Najajreh, Rene Figueredo, James Koropatnick, Wei-Ping Min, Mateusz Rytelewski, Peter J. Ferguson, Mikal El-Hajjar, Faizah Alotaibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e241679c9d9eccd81c0bc05694b1cf9
https://doi.org/10.1002/eji.201948309/v3/response1
https://doi.org/10.1002/eji.201948309/v3/response1
Autor:
Faizah, Alotaibi, Mateusz, Rytelewski, Rene, Figueredo, Ronak, Zareardalan, Meng, Zhang, Peter J, Ferguson, Saman, Maleki Vareki, Yousef, Najajreh, Mikal, El-Hajjar, Xiufen, Zheng, Wei-Ping, Min, James, Koropatnick
Publikováno v:
European journal of immunologyReferences. 50(5)
CD5 is expressed on T cells and a subset of B cells (B1a). It can attenuate TCR signalling and impair CTL activation and is a therapeutic targetable tumour antigen expressed on leukemic T and B cells. However, the potential therapeutic effect of func
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::961b5319a0b4575b4817786f76c28e72
https://pubmed.ncbi.nlm.nih.gov/31943150
https://pubmed.ncbi.nlm.nih.gov/31943150
Autor:
James Koropatnick, Saman Maleki Vareki, Rene Figueredo, Meng Zhang, Ronak Zareardalan, Peter J. Ferguson, Yousef Najajreh, Xiufen Zheng, Faizah Alotaibi, Wei-Ping Min, Mateusz Rytelewski, Mikal El-Hajjar
Publikováno v:
Cancer Research. 80:917-917
Blockade of programmed cell death protein 1 (PD-1) is approved for treatment of multiple human cancers and is the focus of multiple studies due to its key role in T cell function. However, only patients with ‘'hot'' tumors (i.e. those with increase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c0f32ea3e563e47362fd2dd34fb1a8a
https://doi.org/10.1158/1538-7445.am2020-917
https://doi.org/10.1158/1538-7445.am2020-917